Neutrogena-Maker Kenvue Beats Profit Forecast, Ups Sales Outlook

Kenvue reported first-quarter sales of $3.74 billion, topping the $3.68 billion consensus, according to Benzinga. Total sales declined 3.9% year over year due to a 1.2% organic sales drop and a 2.7% foreign currency headwind. Gross margin rose slightly to 58%, while adjusted operating income margin fell to 19.8% from 22%. Kenvue raised its 2025 net sales forecast to a 1% to 3% increase, with organic growth unchanged at 2% to 4%. The company now expects adjusted operating income margin to decline year over year due to tariffs, reversing its earlier projection of improvement. The company appointed Amit Banati as CFO and announced a five-year AI partnership with Microsoft to enhance digital operations.